Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation

NCT ID: NCT03774797

Last Updated: 2021-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

592 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-01

Study Completion Date

2020-08-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to test and disseminate tools that drive successful immediate postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is to reduce unintended pregnancy soon after childbirth by increasing access to immediate postpartum LARC for women who desire it.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based on previous work, the investigators have generated a toolkit to guide the integration of immediate postpartum LARC services into widespread clinical practice. In the proposed work, this toolkit will be used to initiate immediate postpartum LARC services in a single site with low baseline immediate postpartum LARC uptake (Michigan Medicine). The investigators will conduct a feasibility study using mixed methods to assess acceptability and appropriateness of toolkit items; patient experience of care; immediate postpartum LARC utilization rate; and prenatal contraceptive counseling rate.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Related

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-Implementation Patients

Enrolled patients will take online surveys following a prenatal or a postpartum visit.

No interventions assigned to this group

Post-Implementation Patients

All enrolled patients will take online surveys following a prenatal or a postpartum visit. A subset will be interviewed after the postpartum survey.

Implementation Toolkit

Intervention Type OTHER

Post-implementation patients and providers will be assessed after the implementation toolkit has been used to improve service delivery at the study site.

Post-Implementation Providers

All enrolled providers will take online surveys at 6-12 months after program implementation, and a subset will be interviewed.

Implementation Toolkit

Intervention Type OTHER

Post-implementation patients and providers will be assessed after the implementation toolkit has been used to improve service delivery at the study site.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Implementation Toolkit

Post-implementation patients and providers will be assessed after the implementation toolkit has been used to improve service delivery at the study site.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female (patients)
* Pregnant (patients)
* Receiving obstetrical care at Michigan Medicine (patients)
* L\&D provider at Michigan Medicine (providers)

Exclusion Criteria

* non-English speaking
* unable to provide informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Agency for Healthcare Research and Quality (AHRQ)

FED

Sponsor Role collaborator

University of Michigan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michelle H. Moniz

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michelle H. Moniz, MD, MSc

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Vanessa K. Dalton, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Michelle Heisler, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Michigan Medicine

Ann Arbor, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HUM00126810

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Immediate Postplacental IUD Insertion
NCT02169869 TERMINATED NA
Postpartum Family Planning
NCT03844633 TERMINATED PHASE4
Quick Start of Highly Effective Contraception
NCT02076217 ACTIVE_NOT_RECRUITING
Inpatient Adolescent Contraception
NCT04423068 COMPLETED EARLY_PHASE1